ITS DUL and UOL Systems MRI Safety Recall - Class II
Summary
FDA Class II recall initiated for I.T.S. GmbH's DUL and UOL orthopedic implant systems after updated MRI safety testing revealed higher RF-induced temperature increases under certain MRI conditions than previously documented. The affected systems include Distal Ulna Locking and Ulna Osteotomy Locking plates and associated components distributed nationwide.
What changed
I.T.S. GmbH initiated a Class II medical device recall for its DUL and UOL orthopedic implant systems after post-market MRI safety testing demonstrated higher RF-induced heating than originally documented. The updated testing shows increased temperature rises under certain MRI conditions, requiring revision of the Instructions for Use safety information.\n\nHealthcare providers who perform MRI scans on patients with these implants must update their protocols and patient guidance. The recall affects orthopedic surgical facilities using Distal Ulna Locking and Ulna Osteotomy Locking systems. Facilities should distribute Field Safety Notices, update IFU documentation, and advise patients of potential MRI heating risks.
What to do next
- Distribute Field Safety Notice to all healthcare facilities with affected inventory
- Update Instructions for Use with corrected MRI safety parameters
- Alert patients implanted with these devices to inform MRI technicians of updated heating risks
Archived snapshot
Apr 10, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
I.T.S. GmbH
Device Recalls (Class II)
← All Device Recalls (Class II) Class II Z-1604-2026 · 20260401 · Ongoing
Product
I.T.S. DUL (Distal Ulna Locking) System and UOL (Ulna Osteotomy Locking) System with the below descriptions and corresponding article numbers. 1. I.T.S. DUL (Distal Ulna Locking) System, Distal Ul...
Reason for Recall
Updated MRI safety testing demonstrates higher RF-induced temperature increases under certain MRI conditions than previously reflected in the Instructions for Use (IFU).
Distribution
US Nationwide distribution in the states of AL, AZ, BVI, CA, CO, FL, GA, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NE, NJ, NM, NV, OH, OK, PA...
Source: openFDA Enforcement API
Related changes
Get daily alerts for FDA: Device Recalls Class II
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from FDA.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when FDA: Device Recalls Class II publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.